338 related articles for article (PubMed ID: 15701428)
1. Lung transplantation: a decade of experience.
Moffatt SD; Demers P; Robbins RC; Doyle R; Wienacker A; Henig N; Theodore J; Reitz BA; Whyte RI
J Heart Lung Transplant; 2005 Feb; 24(2):145-51. PubMed ID: 15701428
[TBL] [Abstract][Full Text] [Related]
2. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
[TBL] [Abstract][Full Text] [Related]
3. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
[TBL] [Abstract][Full Text] [Related]
4. Induction therapy in lung transplantation: initial single-center experience comparing daclizumab and antithymocyte globulin.
Lischke R; Simonek J; Davidová R; Schützner J; Stolz AJ; Vojácek J; Burkert J; Pafko P
Transplant Proc; 2007; 39(1):205-12. PubMed ID: 17275507
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of lung transplantation for cystic fibrosis--Danish results.
Bech B; Pressler T; Iversen M; Carlsen J; Milman N; Eliasen K; Perko M; Arendrup H
Eur J Cardiothorac Surg; 2004 Dec; 26(6):1180-6. PubMed ID: 15541981
[TBL] [Abstract][Full Text] [Related]
6. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
7. Lung transplantation for cystic fibrosis: 6-year follow-up.
Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
[TBL] [Abstract][Full Text] [Related]
8. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
[TBL] [Abstract][Full Text] [Related]
9. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
[TBL] [Abstract][Full Text] [Related]
10. Single-institution study evaluating the utility of surveillance bronchoscopy after lung transplantation.
Valentine VG; Gupta MR; Weill D; Lombard GA; LaPlace SG; Seoane L; Taylor DE; Dhillon GS
J Heart Lung Transplant; 2009 Jan; 28(1):14-20. PubMed ID: 19134525
[TBL] [Abstract][Full Text] [Related]
11. Lower incidence of bronchiolitis obliterans in pediatric liver-lung transplant recipients with cystic fibrosis.
Faro A; Shepherd R; Huddleston CB; Lowell J; Gandhi S; Nadler M; Sweet SC
Transplantation; 2007 Jun; 83(11):1435-9. PubMed ID: 17565316
[TBL] [Abstract][Full Text] [Related]
12. Rabbit antithymocyte globulin versus OKT3 induction therapy after heart-lung and lung transplantation: effect on survival, rejection, infection, and obliterative bronchiolitis.
Barlow CW; Moon MR; Green GR; Gamberg P; Theodore J; Reitz BA; Robbins RC
Transpl Int; 2001 Aug; 14(4):234-9. PubMed ID: 11512056
[TBL] [Abstract][Full Text] [Related]
13. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD
Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
[TBL] [Abstract][Full Text] [Related]
14. Twenty-year experience of lung transplantation at a single center: Influence of recipient diagnosis on long-term survival.
de Perrot M; Chaparro C; McRae K; Waddell TK; Hadjiliadis D; Singer LG; Pierre AF; Hutcheon M; Keshavjee S
J Thorac Cardiovasc Surg; 2004 May; 127(5):1493-501. PubMed ID: 15116013
[TBL] [Abstract][Full Text] [Related]
15. The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry.
Hachem RR; Edwards LB; Yusen RD; Chakinala MM; Alexander Patterson G; Trulock EP
Clin Transplant; 2008; 22(5):603-8. PubMed ID: 18435784
[TBL] [Abstract][Full Text] [Related]
16. Lung transplantation as the first choice in emphysema.
Delgado M; Borro JM; De La Torre MM; Fernández R; González D; Paradela M; García JA; Fieira E; Rama P
Transplant Proc; 2009; 41(6):2207-9. PubMed ID: 19715874
[TBL] [Abstract][Full Text] [Related]
17. Influence of induction therapy on rejection and survival in heart transplantation.
Almenar L; García-Palomar C; Martínez-Dolz L; Chamorro C; Moro J; Zorio E; Arnau MA; Rueda J; Osa A; Cardo ML
Transplant Proc; 2005 Nov; 37(9):4024-7. PubMed ID: 16386616
[TBL] [Abstract][Full Text] [Related]
18. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
Wang D; Chen JH; Wu WZ; Yang SL; Wu GJ; Wang H; Tan JM
Transplant Proc; 2007; 39(1):69-72. PubMed ID: 17275476
[TBL] [Abstract][Full Text] [Related]
19. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
[TBL] [Abstract][Full Text] [Related]
20. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab.
Burton CM; Andersen CB; Jensen AS; Iversen M; Milman N; Boesgaard S; Arendrup H; Eliasen K; Carlsen J
J Heart Lung Transplant; 2006 Jun; 25(6):638-47. PubMed ID: 16730569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]